Racura Oncology, an Australian Phase 3 stage clinical biopharmaceutical company, reports the discovery of the primary mechanism of action (MOA) of its lead oncology asset, (E,E)-bisantrene. Bisantrene ...
Opus Genetics, Inc. (Nasdaq: IRD) ('Opus Genetics” or the 'Company”), a clinical-stage biopharmaceutical company developing ...
The designs were required to incorporate three or more Formica ® Brand, FENIX ® Innovative Materials or other products from the Formica ® Portfolio of Surfacing Solutions and could be used in ...
A 52% increase from baseline in mean C-peptide AUC at Week 12 in patients diagnosed within 0–3 years (n=5) receiving ...
By the authority vested in me as President by the Constitution and the laws of the United States of America, it is hereby ordered: Section 1. Purpose.
This useful study identified XAP5 as an ancient transcriptional regulator critical for primary ciliogenesis. The evidence supporting the conceptual framework linking evolutionary conservation to ...
A discussion of the rapid integration of AI in the US insurance industry, the legal and ethical challenges arising from AI ...
A new McGill-led study reveals that digital brain exercises can rejuvenate aging brain systems responsible for learning and memory. Older adults using BrainHQ for 10 weeks showed restored cholinergic ...
Stoke Therapeutics, Inc.: late-stage zorevunersen for SCN1A Dravet Syndrome with durable 3-year data, Phase 3 EMPEROR and ...
Over the past year, we have carefully considered whether — and how — life sciences companies can use AI tools in their clinical development ...
UNC has officially opened a new office in Washington, D.C., which the university is dubbing "Carolina in the Capital." ...
With the 2026 NBA Draft Lottery on the horizon, we run one final simulation and project all 60 picks in a loaded class, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results